medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Estimating the burden of SARS-CoV-2 in France
Henrik Salje1,2,*, CÃ©cile Tran Kiem,1,3,*, NoÃ©mie Lefrancq1, NoÃ©mie Courtejoie4, Paolo Bosetti1,
Juliette Paireau1, Alessio Andronico1, NathanaÃ«l HozÃ©1, Jehanne Richet4, Claire-Lise Dubost4,
Yann Le Strat5, Justin Lessler6, Daniel Levy Bruhl7, Arnaud Fontanet8, Lulla Opatowski9, PierreYves Boelle10, Simon Cauchemez1
1.
2.
3.
4.
5.

Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, France
Department of Genetics, University of Cambridge, UK
Sorbonne UniversitÃ©, Paris, France
DREES, MinistÃ¨re des SolidaritÃ©s et de la SantÃ©, Paris, France
French Institute for Public Health Surveillance, Data Science Division, Saint-Maurice,
France
6. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore,
USA
7. Direction des Maladies Infectieuses, SantÃ© Publique France, Saint-Maurice, France
8. Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
9. Institut National de la SantÃ© et de la Recherche MÃ©dicale, UnitÃ© Mixte de Recherche 1181,
UniversitÃ© Versailles St-Quentin-en-Yvelines, Institut Pasteur, Paris, France
10. INSERM, Sorbonne UniversitÃ©, Institut Pierre Louis dâ€™EpidÃ©miologie et de SantÃ© Publique,
Paris, France
*These authors contributed equally to the work

Correspondence to:
Simon Cauchemez
Mathematical Modelling of Infectious Diseases Unit
Institut Pasteur
28 rue du Dr Roux
Paris 75015
simon.cauchemez@pasteur.fr

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

1

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Abstract
France has been heavily affected by the SARS-CoV-2 epidemic and went into lockdown on the 17th
March 2020. Using models applied to hospital and death data, we estimate the impact of the
lockdown and current population immunity. We find 2.6% of infected individuals are hospitalized
and 0.53% die, ranging from 0.001% in those <20y to 8.3% in those >80y. Across all ages, men
are more likely to be hospitalized, enter intensive care, and die than women. The lockdown reduced
the reproductive number from 3.3 to 0.5 (84% reduction). By 11 May, when interventions are
scheduled to be eased, we project 3.7 million (range: 2.3-6.7) people, 5.7% of the population, will
have been infected. Population immunity appears insufficient to avoid a second wave if all control
measures are released at the end of the lockdown.

2

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Main
The worldwide pandemic of SARS-CoV-2, the coronavirus which causes COVID-19, has resulted
in unprecedented responses, with many affected nations confining residents to their homes. Much
like the rest of Europe, France has been hit hard by the epidemic and went into lockdown on the
17th March. It was hoped that this would result in a sharp decline in ongoing spread, as was
observed when China locked down following the initial emergence of the virus (1). Following a
reduction in cases, the government has announced it will ease restrictions on the 11th May. In order
to appropriately exit from the lockdown, we need to understand the underlying level of population
immunity and infection, identify those most at risk for severe disease and the impact of current
control efforts.
Daily reported numbers of hospitalizations and deaths only provide limited insight into the state of
the epidemic. Many people will either develop no symptoms or symptoms so mild they will not be
detected through healthcare-based surveillance. The concentration of hospitalized cases in older
individuals has led to hypotheses that there may be widespread â€˜silentâ€™ transmission in younger
individuals. For example, it has been suggested that up to half the UK population may have been
infected by the middle of March, despite under 100 deaths reported at that time (2). If the majority
of the population is infected, viral transmission would slow, potentially reducing the need for the
stringent intervention measures currently employed.
Here, we present a suite of modelling analyses to characterize the dynamics of SARS-CoV-2
transmission in France and the impact of the lockdown on these dynamics. We elucidate the risk of
SARS-CoV-2 infection and severe outcomes by age and sex and estimate the current proportion of
the national and regional populations that have been infected and might be at least temporarily
immune (3). These models support healthcare planning of the French government by forecasting
Intensive Care Unit (ICU) bed capacity requirements.
As of 14 April 2020, there had been 71,903 incident hospitalizations due to SARS-CoV-2 reported
in France and 10,129 deaths in hospitals, with the east of the country and the capital, Paris,
particularly affected (Figure 1A-B). The mean age of hospitalized patients was 68y and the mean
age of the deceased was 79y with 50.0% of hospitalizations occurring in individuals >70y and 81.6%
of deaths within that age bracket; 56.2% of hospitalizations and 60.3% of deaths were male (Figures
1C-E). Hospitalization and death data only capture the most severe infections. To reconstruct the
dynamics of all infections, including mild ones, we jointly analyze them with data documenting the
risk of death among persons infected by SARS-CoV-2 coming from a detailed investigation of an
outbreak aboard the Princess Diamond cruise ship where all passengers were subsequently tested
(719 infections and 13 deaths). By coupling the French passive surveillance hospital data with the
active surveillance performed aboard the Princess Diamond, we can disentangle the risk of being
hospitalized in those infecte
d from the underlying probability of infection (4â€“6).
We find that 2.6% of infected individuals are hospitalized (95% CrI: 1.4-4.4), ranging from 0.09%
(95% CrI: 0.05-0.2) in females under <20y to 31.4% (95% CrI: 16.7-52.6) in males >80y (Figure 2A,

3

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Table S1). Once hospitalized, 18.2% (95% CrI: 18.0%-18.6%) patients enter ICU after a mean delay
of 1.5 days (Figure S1). There is an increasing probability of entering ICU with age - however, this
drops for those >70y (Figure 2B, Table S2). Overall, 20.0% (95% CrI: 19.6-20.4) of hospitalized
individuals go on to die (Figure 2C). The overall probability of death among those infected (the
Infection Fatality Ratio, IFR) is 0.53% (95% CrI: 0.28-0.88), ranging from 0.001% in those under
20y to 8.3% (95% CrI: 4.4-13.9) in those >80y (Figure 2D, Table S2). Our estimate of overall IFR
is similar to other recent studies that found values of between 0.5%-0.7% for the Chinese epidemic
(5, 8, 9). We find men have a consistently higher risk than women of hospitalization (RR 1.26, 95%
CrI: 1.21-1.31), ICU admission once hospitalized (RR: 1.69, 95% CrI: 1.61-1.78) and death (RR:
1.45, 95% CrI: 1.26-1.74) across all age groups (Figure S2).
We identify two clear subpopulations in delays between hospitalization and death: individuals that
die quickly upon hospital admission (15% of fatal cases, mean time to death of 0.67 days) and
individuals who die after longer time periods (85% of fatal cases, mean time to death of 13.2 days)
(Figure S3). The proportion of fatal cases who die rapidly remains approximately constant across
age-groups (Figure S4, Table S3). These observations, combined with the substantial differences
in risk of death by age and sex, suggest complex patterns of disease manifestation. The underlying
mechanisms that can explain why subsets of the population are substantially more at risk than
others remain unclear although a role for immunopathogenesis has been proposed, including
through antibody-dependent enhancement, where non-neutralizing antibodies trigger an immune
response through cytokine storms, and cell-based enhancement, such as with allergic inflammation
(10â€“12). Understanding these processes with regards to SARS-CoV-2 will be key to the
development of a safe vaccine.
We next fit national and regional transmission models for the epidemic to ICU admission and bed
occupancy (Figure 3A-B, Figure S5, Tables S4-S6). We find that the basic reproductive number R0
prior to the implementation of the lockdown was 3.31 (95% CrI: 3.18-3.43). At a national level, the
lockdown resulted in a 84% reduction in transmission, with the reproduction number R dropping to
0.52 (95% CrI: 0.50-0.55). We forecast that by the 11th May, 3.7 million (range 2.3 - 6.7, when
accounting for uncertainty in the probability of entering ICU) people will have been infected,
representing 5.7% (range 3.5 - 10.3) of the French population (Figure 3E). This proportion will be
12.3% (range 7.9-21.3) in Ile-de-France, which includes Paris, and 11.8% (range 7.4-20.5) in Grand
Est, the two most affected regions of the country (Figure 3D, Figure S5). Assuming a basic
reproductive number of R0=3.3, it would require around 70% of the population to be immune for the
epidemic to be controlled by immunity alone. Our results therefore strongly suggest that, without a
vaccine, herd immunity on its own will be insufficient to avoid a second wave at the end of the
lockdown. Efficient control measures need to be maintained beyond the 11th May.
Our model projections can help inform the ongoing and future response to COVID-19. National ICU
daily admissions have gone from 700 at the end of March to 220 on the 14th April. If current trends
continue, by the 11th May we project between 10 and 45 ICU daily admissions, between 1370 and
1900 ICU beds occupied by COVID-19 cases as well as 1300 (range 840 - 2300) daily infections,
down from between 270,000-770,000 immediately prior to the lockdown. However, it is important
to emphasize that these dynamics and forecasts may change quickly and so extreme caution is

4

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

needed. For example, after an initial important drop, we note that ICU admissions have plateaued
in the last few days. In addition, other external factors, such as temperature fluctuations may affect
the dynamics over time (13).
Using our framework, we are able to recover the observed number of hospitalizations by age and
sex in France and the number of deaths in the Princess Diamond (Figure S6). As a validation, our
approach is also able to recover parameters in simulated datasets where the true values are known
(Figure S7). We run a suite of sensitivity analyses that considers additional future COVID-19 deaths
on the Princess Diamond, longer delays between symptom onset and ICU admission, equal attack
rates across all ages, reduced infectivity in younger individuals, a contact matrix with unchanged
structure before/during the lockdown and one with extremely high isolation of elderly individuals
during the lockdown. These different scenarios result in mean IFRs ranging from 0.4% to 0.7%, the
level of immunity in the population by the 11 May ranging from 1.9-12.5, the number of daily
infections at this date ranging from 200-4600 and a range of reproductive numbers post lockdown
of 0.38-0.64 (Figure 4, Figures S8-S10).
Here, we focused on deaths occurring in hospitals. There are also non-hospitalized COVID-19
deaths. For example there have been >6,000 non-hospitalized deaths in retirement homes in
France (14). We explicitly removed these communities from our analyses as transmission dynamics
may be different in these closed communities, therefore these do not affect our estimates of
immunity in the general population. A number of additional non-hospitalized deaths may also be
occurring, in which case we would underestimate the proportion infected.
This study shows the massive impact the French lockdown had on SARS-CoV-2 transmission. It
estimates underlying probabilities of infection, hospitalization and death, which is essential for the
interpretation of COVID-19 surveillance data. The forecasts we provide can inform planning of ICU
bed occupancy and lockdown exit strategies. The estimated low level of immunity against SARSCoV-2 indicates that efficient control measures that limit transmission risk will have to be maintained
beyond the 11th May to avoid a rebound of the epidemic.

5

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Methods
Case data
We work with daily hospitalization and death data from the SI-VIC database, maintained by the
ANS (Agence du NumÃ©rique en SantÃ©, formerly named ASIP) and sent daily to SantÃ© Publique
France, the French national public health agency. This database provides real time data on the
COVID-19 patients hospitalized in French public and private hospitals, including their age, date of
hospitalization and region. All cases are either biologically confirmed or present with a computed
tomographic image highly suggestive of SARS-CoV-2 infection. The SI-VIC web portal was
activated for the COVID-19 epidemic on 13 March 2020, with a progressive increase in the number
of hospitals transmitting data. Every day, we receive a case line-list with the latest hospitalization
status of each patient. We collate the daily files for metropolitan France to reconstruct individual
trajectories from hospital admission to discharge or death. We report as hospitalized in ICU patients
hospitalized in â€œHospitalisation rÃ©animatoire (RÃ©animation, soins intensifs or unitÃ© de surveillance
continue)â€.
Since the status of each patient is updated with a few days of delay, we correct the observed time
series for these reporting delays. Let ğ»",$ denote the number of hospital admissions that were
reported for time ğ‘¡ at time ğ‘‡of the epidemic (ğ‘¡ â‰¤ ğ‘‡). Let ğ‘",$ denote the probability that a hospital
admission that occured at time ğ‘¡ has been reported before time ğ‘‡. We estimate this probability from
the cumulative distribution of hospital admissions reporting delays estimated from the SI-VIC
database. We correct the observed time series of hospital admissions at time ğ‘‡ by sampling the
expected number of hospital admissions at time ğ‘¡ ğ»",$ that have not been reported yet from:
ğ»",$ âˆ¼ ğ‘ğµ(ğ»",$ , ğ‘",$ )
where ğ‘ğµis a negative binomial distribution. We then compute the expected number of hospital
admissions corrected for reporting delays as:
/",$ = ğ»",$ + ğ»",$
ğ»
In order to take into account the variations of the reporting delays with the day of the week (from
e.g., reduced reporting over weekends), we estimate different probabilities ğ‘",$ according to the day
of the week of ğ‘¡ and ğ‘‡. We apply the same method to correct the daily time series of ICU admissions,
deaths and discharges, as well as ICU releases in order to compute the corrected times series of
occupied ICU beds.
Since the SI-VIC web portal started recording COVID-19 cases on March 13th, a certain number of
hospital admissions prior to or around this date may have been missed. We therefore adjusted the
data from this database before March 15th by using data on hospital admissions collected by the
OSCOURÂ® network. This surveillance system was created in 2004. It collects data on patients
presenting to emergency departments in all regions of France. To correct the SI-VIC data we
computed the median ratio between hospital admissions in the SI-VIC and in the OSCOURÂ®
6

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

datasets past March 15th and multiplied by the same ratio to the OSCOURÂ® data before March 15th
(see Figure S11).

Active surveillance data
The Princess Diamond is a cruise ship that suffered a SARS-CoV-2 outbreak in early February
2020. All individuals on board were tested. Out of 3711 passengers, 712 tested positive (15, 16).
The age distribution of the positive individuals is available for a subset of 619 individuals (15). We
assume that the age distribution of the remaining 93 individuals who tested positive is the same.
There have been 13 deaths, seven were individuals in their 70s, four were in their 80s, one in their
60s. No age was reported for one death.

Estimating delays from hospitalization to death and from hospitalization to ICU
In a growing epidemic, the time to death among individuals who have already experienced the
outcome will be an underestimate of overall time to death, as many of those who take longer will
not yet have died. We need to account for these delays when estimating the infection fatality ratio
as otherwise we would underestimate the probability of death (8).
To capture the delay to death for the different age groups we use data from cases throughout
France that had dates of hospitalization and dates of death. We assume that the delays follow a
lognormal distribution as this has previously been shown to work well for SARS-CoV-2 infections
(17).
We use the number of hospitalizations on a given day to account for the state of the epidemic at
that time, similar to what has previously been used (5). We note that a subset of individuals die
within a short period of time after entering hospital. We therefore use a mixture distribution
composed of an exponential distribution for those that die within a short delay and a lognormal
distribution for those that die after longer delays (Figure S3).

We denote by ğœ‹4 "567 the true probability density function (pdf) of the delay, and ğœ‹4 89: the observed
density, which will be biased to be right skewed as most individuals will not have had their outcome.
We denote by ğ›±4 "567 and ğ›±4 89: their cumulative density functions (cdf), respectively. We can
approximate the expected delay distribution ğœ‹4 7<= , for a given age group i, at a given time T during
the epidemic, thereby adjusting for the stage of the epidemic, given the true pdf for the delay ğ›±4 "567
using the following adjustment:

7

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

where ğ»4,>

is the total number of hospitalized cases of age i at time j.

For the correct pdf ğ›±4 "567 , we should have:

We estimate parameters of the true delay from hospitalization to death distribution ğœ‹4 "567 for each
group in turn by minimizing the sum of squared error (SSE) of the distribution ğœ‹4 7<= to the observed
data ğœ‹4 89: . Given the small number of deaths in younger age groups, we consider three age groups:
<70y, 70-80, 80+. To get an overall estimate, we also repeat the calculation using all individuals
across all age groups.
To fit the delays from hospitalization to ICU admission we use the same approach, however, we
consider the delays are constant across age groups and that they follow an exponential distribution
(Figure S1).

Modeling the risk of hospitalization, ICU admission and death
We consider the population of mainland France for the transmission model in eight age bands
(<20y, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80+) and consider males and females separately.
We exclude the population in retirement communities (N=730,000 individuals, mainly over the age
of 70 and 74% female), as there have been a number of outbreaks in these enclosed communities
and the underlying risk of infection in these locations is unlikely to be the same as the wider
population. Deaths in these communities are not captured in hospital records.
Outside retirement communities, we assume that all recorded deaths occurred in hospital and that
the probability of death is linked to age and sex.
As SARS-CoV-2 is principally transmitted from close contact between individuals, we assume that
the probability of infection is proportional to the number of contacts an individual makes, which has
previously been measured for individuals in France (7).

Where ğ›¬ represents the mean cumulative probability of having been infected across the entire
population and ğ›½4 represents the relative risk of infection for an individual of age i compared to a
randomly selected person from the population. For ğ›½4 , we use the mean number of contacts that an
8

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

individual of age group i has on a daily basis as measured in France, weighted by the proportion of
the population that is within age group i (7).
In order to disentangle the underlying probability of infection from the probability of hospitalization
and death, we use the results of an active surveillance campaign in a different population (cruise
ship) where all individuals were tested, and therefore the probability of detection is not linked to the
presence of severe disease that requires hospitalization. Where the age of the individuals is
reported, we can estimate the probability of death given infection for each age group.
For the passive French hospital surveillance system, we use a Poisson Likelihood for the number
of hospitalizations, ICU admissions and deaths within each age group and sex.

Where ğœ‡B8:=,4,> is the probability of hospitalization for an individual within age group i of sex j, ğœ‡CDE,4,>
is the probability of entering ICU and ğœ‡F7G"H,4,> is the probability of death for hospitalized individuals
within age group i of sex j. ğœƒJ is the proportion of hospitalized individuals in the dataset that have
experienced their ICU outcome and ğœƒK ,i is the proportion of individuals of age group i that have
experienced their death outcome.
For the active surveillance portion of the model, we use a Poisson likelihood to capture the number
of deaths on the Princess Diamond cruise ship. We assume that sufficient time has passed that all
deaths that were going to occur by the passengers as a result of SARS-CoV-2 infection have now
occurred. However, we conduct a sensitivity analysis where half of the remaining six patients that
are still within ICU go on to die.

As this is a growing epidemic, many of the hospitalizations may yet end up being fatal. To adjust
for this, we estimate the proportion of current hospitalizations where the outcome is known.
ğœƒK,4 represents the proportion of hospitalizations, where the death outcome is known for an individual
of age i.
To estimate ğœƒK,4 , we calculate the proportion of hospitalized individuals who have already
experienced their outcome (18).

9

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Where ğ¶4,> is the number of cases at time j of age i and ğœ‹4,> is the proportion of all hospitalized cases
in our dataset of age i that have a delay between hospitalization and death of j days.
We take a similar approach to estimate the proportion of hospitalized individuals who have
experienced their ICU outcome (ğœƒJ ).
We use RStan (19) to fit the ğœ‡B8:=,4,> , ğœ‡CDE,4,> , ğœ‡F7G"H,4,> and ğš² parameters using logit transformed
parameters. We run four chains of 10,000 iterations each and remove 50% for burn-in. We use
2.5% and 97.5% percentiles from the resulting posterior distributions for 95% credible intervals for
the parameters. To calculate the overall probability of hospitalization following infection for the
whole population we compute an average across the individual ğœ‡B8:=,4,> estimates, weighted by the
estimated number of people infected in each age-sex group. Similarly, to calculate the overall
probability of death following hospitalisation, we compute an average across the individual ğœ‡F7G"H,4,>
estimates, weighted by the estimated number of people hospitalised in each age-sex group.

Transmission model fit to ICU data
We use a deterministic compartmental model stratified by age to describe the transmission of
SARS-CoV-2 in the French population. Upon infection, susceptible individuals will enter a latent
compartment (first exposed compartment ğ¸K), in which they will on average stay 4.0 days. During
this period, they are not infectious. They will then move to a second exposed compartment ğ¸Jin
which they will on average stay 1.0 day. Upon entry in the ğ¸J compartment, infected individuals
become infectious. They then move to the compartment I where they stay for an average duration
of 3 days, where all individuals are infectious and a subset develop symptoms. This parametrization
gives a mean incubation period of 5 days and allows for one day of pre-symptomatic transmissions,
in the line with several estimates from Chinese data (20, 21). It is also in line with generation interval
estimates obtained from analyses of infector-infectee pairs from mainland China (20).
A subset of infected individuals develop severe disease that results in ICU admission. The
probability of ending up in ICU admission depends on age (ğœ‡B8:=,4 Ã— ğœ‡CDE,4 for age i). Finally, we
assume that patients will enter ICU on average 7 days after symptom onset, consistent with
previous estimates (22).
The model is initiated with ğ¼Q cases in the ğ¸Kcompartment on the 22nd January 2020 (ğ‘¡Q ).

Contacts patterns in the French population prior to the lockdown

10

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Age-specific daily contacts for the French population are obtained from the study COMES-F
performed in 2012 (7) . From this survey, we reconstruct the contact matrix describing mixing
between age classes during a non-holiday period. To compute the matrix, we divide the population
equally from 0 to 80 years old into 8 classes of ten years each. For the elderly, we consider one
unique class that contains over-80 years old people. Daily contacts are computed by taking into
account the variability associated with the weekend/weekdays seasonality. Data on contacts are
retrieved and computed using the SocialmixR package (23).

Computing the transmission rate prior to the lockdown
From the definition of the contact matrix, the parametrization of our transmission model and a given
reproduction number ğ‘…Q , we can obtain the following expression for the transmission rate ğ›½(24,
25):
ğ›½

=

ğ‘…0
ğ· â‹… ğ‘šğ‘ğ‘¥ ğ¸ğ‘–ğ‘”ğ‘’ğ‘›ğ‘£ğ‘ğ‘™ [ğ¶]

where ğ‘šğ‘ğ‘¥ ğ¸ğ‘–ğ‘”ğ‘’ğ‘›ğ‘£ğ‘ğ‘™ [ğ¶]is the maximum eigenvalue of the contact matrix ğ¶ and ğ·is the mean
infectious period.

Trajectories of patients in ICU
We assume that the time spent in ICU is constant across age-groups and that it follows a Gamma
distribution of shape 2 and of rate ğ‘” 86" . This is modelled as two separate compartments for
trajectories in ICU, from which individuals in ICU go out at rate ğ‘” 86" . The mean time spent in ICU
is thus equal to 2/ğ‘” 86" .

Impact of the lockdown on transmission
In response to the growing epidemic, from March 17th, the French population was asked to remain
confined to their homes and to avoid non-essential movement outside the household (26).
We adjusted our contact matrix to reflect the impact on the lockdown on the distribution of daily
contacts between individuals after this date. We denote ğ¶, the contact matrix prior to the lockdown
(7) and transmission rates prior to the lockdown are modelled asğ›½ğ¶ .
In order to model the impact of the lockdown on transmission, one potential approach is to predict
how the standard contact matrix ğ¶ is modified during the lockdown due to reductions in contacts in
different settings. If we denote ğ¶ğ¿ the predicted contact matrix during the lockdown period, the
transmission rates for the lockdown period would then simply be ğ›½ğ¶ğ¿. However, a limitation of this
approach is that given the unprecedented nature of the lockdown, it is hard to predict precisely what

11

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

the new contact matrix ğ¶ğ¿ may look like. Any slight error in the assumed reduction of the average
number of contacts would have a strong impact on estimates of the reproduction number for the
lockdown period.
To avoid such risk, we instead estimate a transmission parameter separately for the time period
before (ğ›½) and during the lockdown (ğ›½d8efg8hi ). Comparison of these two parameters will determine
the reduction in the reproduction number due to the lockdown. Since the reduction in average
number of contacts will be captured by transmission parameters (ğ›½, ğ›½d8efg8hi ), we work with
normalized contact matrices, i.e. contact matrices whose maximum eigenvalues are equal to 1.
This allows us to define ğ›½as ğ‘…Q /ğ· and ğ›½d8efg8hi as ğ‘…j8efg8hi /ğ· and to compute transmission rates
before and after lockdown as ğ›½ğ¶ and ğ›½j8efg8hi ğ¶ğ¿. We modify the contact matrix for the lockdown
to capture the impact of the lockdown on the structure of the matrix. This normalization ensures that
estimates of R after the lockdown are little impacted by the matrix we choose (see Figure 4).
The normalized contact matrices we consider for the lockdown matrices are:
- ğ¶ğ¿K (baseline): the original contact matrix by removing all contacts in school settings and
further assume a reduction of 80% in the contacts associated with the workplace and 90%
in the ones outside work and home. This represents our baseline assumptions.
- ğ¶ğ¿J (Children Less Inf - children less infectious): same as ğ¶ğ¿K but where those aged <20 y.o.
are 50% less infectious.
- ğ¶ğ¿k (CM No Change - contact matrix no change): the original (pre-lockdown) contact matrix
(i.e. no change in the matrix).
- ğ¶ğ¿l (CM SDE - contact matrix social distancing elderly): same as ğ¶ğ¿K but with a further 60%
reduction in all contacts of individuals aged over 70y.
- ğ¶ğ¿m (Constant AR - constant attack rates): all the coefficients of the contact matrix are equal
to 1 (homogeneous mixing of the population).
We note that ğ¶ğ¿k and ğ¶ğ¿l are less likely to represent the true situation than ğ¶ğ¿K andğ¶ğ¿J . ğ¶ğ¿l would
lead to only very few contacts for the elderly, and the model then predicts a substantial drop in the
proportion of elderly individuals in ICU. Such reduction in ICU was not observed in France.
Additionally, in the context of lockdowns that apply to the whole population, a recent study reports
a fairly constant reduction in mean contacts across age classes from 18 years old and upwards
before and after the lockdown (27)

Statistical framework for the transmission model
We fit the transmission model using a Bayesian framework and jointly infer parameters. To do this
we let ğ´ğ‘‘ğ‘šCDE =57g ( ğ‘¡) and ğ¼ğ¶ğ‘ˆ =57g ( ğ‘¡) denote respectively the number of admissions in ICU and
the number of ICU beds on day ğ‘¡ predicted by our model. We then let ğ´ğ‘‘ğ‘šCDE e85 (ğ‘¡) and ğ¼ğ¶ğ‘ˆ e85 ( ğ‘¡)
respectively denote the corrected number of ICU admissions and the corrected number of ICU beds
occupied on day ğ‘¡. The likelihood function until day ğ‘‡is:

12

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

$

ğ¿$ = q

ğ‘”(ğ´ğ‘‘ğ‘šCDE e85 ( ğ‘¡) | ğ´ğ‘‘ğ‘šCDE =57g ( ğ‘¡)) â‹… ğ‘”(ğ¼ğ¶ğ‘ˆ e85 (ğ‘¡) | ğ¼ğ¶ğ‘ˆ =57g ( ğ‘¡))

" r "s

where ğ‘”( â‹… | ğ‘‹) is a negative binomial distribution of mean ğ‘‹and overdispersion parameter ğ‘‹ v ,
ğ›¿being a parameter to be estimated. We calibrate the model on corrected SI-VIC data from the 15th
of March (denoted ğ‘¡K ).
The parameter space is explored by Markov Chain Monte Carlo sampling. We implement a
Metropolis-Hastings (MH) algorithm with lognormal proposals for all the parameters and uniform
priors. Chains are run for 10,000 iterations with 2,000 iterations of burn-in.
In early attempts to estimate model parameters, the initial number of cases at the start of the
simulation ğ¼Q was highly correlated to the reproduction number. This is because slight variations in
ğ¼Q or the reproduction number can lead to major changes in the trajectory of cumulative number of
cases. We therefore re-parameterized the model to reduce this correlation by using a proxy for the
number of incident cases at the time of the lockdown ğ¼j8efg8hi .
ğ‘™ğ‘œğ‘” ğ¼Q = ğ‘™ğ‘œğ‘” ğ¼j8efg8hi âˆ’ ğ‘Ÿ(ğ‘¡j8efg8hi âˆ’ ğ‘¡Q )
Where ğ¼Q is the initial number of cases and r is the epidemic growth rate before the lockdown. We
use the approach by Wallinga et al. (28) to relate the basic reproduction number to the epidemic
growth rate ğ‘Ÿ.

Incorporation of uncertainty from the probability of entering ICu following uncertainty
We incorporate uncertainty from the probability of entering ICU following infection in our estimates
of the number of new infections and the immunity in the population over time. To do this, we
separately rerun the transmission model using the 2.5% and 97.5% quantiles from the posterior of
ğœ‡B8:=,4 Ã— ğœ‡CDE,4 . The results of these estimates are included in Figures 3C, 3E, 4D,4E and S4(A-M)3.
Uncertainty in these parameters had little effect on our estimates of the number of required ICU
beds and ICU admissions.

Simulation study to assess model performance in estimating IFR and hospitalization risk
To assess the performance of the approach to estimate probabilities of infection, hospitalization,
ICU entry, and death, we developed a simulation framework where the true parameters (ğœ‡B8:=,4 ,
ğœ‡CDE,4 ,ğš², ğœ‡F7G"H,4 ) were known.
For a period of 45 days we simulate a growing epidemic, seeded by a single infection, where the
number of cases grows exponentially each day with an exponential growth rate of 0.3. We assume

13

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

a population with the same age structure as France and assume no difference in risk of infection
by age or sex. For each of the infections in the simulation we assign:
- The age group, i, drawn according to the age distribution of France
- Whether or not the individual was hospitalized, using a random draw from a Bernoulli
distribution with parameter ğœ‡B8:=,4
- If the individual was hospitalized, whether or not the individual entered ICU, using a random
draw from a Bernoulli distribution with parameter ğœ‡CDE,4
- If the individual was hospitalized, whether or not the individual died, using a random draw
from a Bernoulli distribution with parameter ğœ‡F7G"H,4
- If the individual was hospitalized, the day of hospitalization using an exponential distribution
with a mean of 11 days.
- If the individual entered ICU, the delay from hospitalization to ICU using a random draw from
an exponential distribution with a mean of 2 days.
- If the individual died, the delay from hospitalization to death using a random draw from an
exponential distribution with a mean of 15 days.
We then compute the total counts of hospitalizations, ICU and deaths by age over the first 45 days
of the simulation (Figures S7).
To simulate active surveillance, we select a random subset of 1000 individuals that were infected
and record the outcome (death or not) and age for all of them (irrespective of delays to death).
We use the simulated data to estimate the proportion of cases with outcome observed (ğœƒ) and the
model parameters using our probabilistic framework.

14

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figures
Figure 1

Figure 1. (A) Cumulative number of hospitalizations, ICU admissions and deaths from SARS-CoV2 in France. The green line indicates the time when the lockdown was put in place in France. (B)
Distribution of deaths in France. Number of (C) hospitalizations, (D) ICU and (E) deaths by age
group and sex in France.

15

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure 2

Figure 2. (A) Probability of hospitalization among those infected as a function of age and sex. (B)
Probability of ICU admission among those hospitalized as a function of age and sex. (C) Probability
of death among those hospitalized as a function of age and sex. (D) Probability of death among
those infected as a function of age and sex. For each panel, the black line and grey shaded region
represents the overall mean across all ages. The boxplots represent the 2.5, 25, 50, 75 and 97.5
percentiles of the posterior distributions.

16

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure 3

Figure 3. (A) Daily admissions in ICU in metropolitan France. (B) Number of ICU beds occupied in
metropolitan France. (C) Daily new infections in metropolitan France (logarithmic scale). (D)
Predicted proportion of the population infected by May 11th 2020 for each of the 13 regions in
metropolitan France. (E) Predicted proportion of the population infected in metropolitan France. The
black circles in panels A and B represent hospitalization data used for the calibration and the open
circles hospitalization data that were not used for calibration. The dotted lines in panels C and E
represent the 95% uncertainty range stemming from the uncertainty in the probability of entering
ICU following infection.

17

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure 4

Figure 4. Sensitivity analysis considering different modelling assumptions (A) Predicted daily
ICU admissions on May 11th. (B) Predicted ICU beds on May 11th. (C) Predicted daily new
infections on May 11th. (D) Predicted proportion of the population infected by May 11th. (E)
18

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Estimated basic reproduction number before lockdown. (F) Estimated reproduction number during
lockdown. The different scenarios correspond to: Children less inf. - Individuals <20y are half as
infectious as adults ; No Change CM - the structure of the contact matrix is not modified by the
lockdown ; CM SDE - Contact matrix after lockdown with social distancing of the elderly ; Constant
AR - Attack rates are constant across age groups ; Higher delays - 9 days on average between
illness onset and ICU admission instead of 7 days ; More deaths DP - Three additional deaths will
occur amongst the six passengers of the Diamond Princess cruise ship that are still in ICU. For
estimates of ICU admissions, ICU beds and reproduction numbers before and after lockdown, we
report 95% credible intervals. For estimates of daily new infections and proportion of the population
infected by May 11th, we report the 95% uncertainty range stemming from the uncertainty in the
probability of entering ICU given infection.

19

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

References
1.

M. U. G. Kraemer, C.-H. Yang, B. Gutierrez, C.-H. Wu, B. Klein, D. M. Pigott, Open COVID-19
Data Working Group, L. du Plessis, N. R. Faria, R. Li, W. P. Hanage, J. S. Brownstein, M.
Layan, A. Vespignani, H. Tian, C. Dye, O. G. Pybus, S. V. Scarpino, The effect of human
mobility and control measures on the COVID-19 epidemic in China. Science (2020),
doi:10.1126/science.abb4218.

2.

J. LourenÃ§o, R. Paton, M. Ghafari, M. Kraemer, C. Thompson, P. Simmonds, P. Klenerman,
S. Gupta, Fundamental principles of epidemic spread highlight the immediate need for largescale serological surveys to assess the stage of the SARS-CoV-2 epidemic. medRxiv (2020)
(available at https://www.medrxiv.org/content/10.1101/2020.03.24.20042291v1.abstract).

3.

L. Bao, W. Deng, H. Gao, C. Xiao, J. Liu, J. Xue, Q. Lv, J. Liu, P. Yu, Y. Xu, F. Qi, Y. Qu, F. Li,
Z. Xiang, H. Yu, S. Gong, M. Liu, G. Wang, S. Wang, Z. Song, W. Zhao, Y. Han, L. Zhao, X.
Liu, Q. Wei, C. Qin, Reinfection could not occur in SARS-CoV-2 infected rhesus macaques, ,
doi:10.1101/2020.03.13.990226.

4.

J. Lessler, H. Salje, M. D. Van Kerkhove, N. M. Ferguson, S. Cauchemez, I. RodriquezBarraquer, R. Hakeem, T. Jombart, R. Aguas, A. Al-Barrak, D. A. T. Cummings, MERS-CoV
Scenario and Modeling Working Group, Estimating the Severity and Subclinical Burden of
Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia. Am.
J. Epidemiol. 183, 657â€“663 (2016).

5.

R. Verity, L. C. Okell, I. Dorigatti, P. Winskill, C. Whittaker, N. Imai, G. Cuomo-Dannenburg, H.
Thompson, P. G. T. Walker, H. Fu, A. Dighe, J. T. Griffin, M. Baguelin, S. Bhatia, A. Boonyasiri,
A. Cori, Z. CucunubÃ¡, R. FitzJohn, K. Gaythorpe, W. Green, A. Hamlet, W. Hinsley, D. Laydon,
G. Nedjati-Gilani, S. Riley, S. van Elsland, E. Volz, H. Wang, Y. Wang, X. Xi, C. A. Donnelly,
A. C. Ghani, N. M. Ferguson, Estimates of the severity of coronavirus disease 2019: a modelbased analysis. Lancet Infect. Dis. (2020), doi:10.1016/S1473-3099(20)30243-7.

6.

P. G. T. Walker, C. Whittaker, O. Watson, M. Baguelin, K. E. C. Ainslie, S. Bhatia, S. Bhatt, A.
Boonyasiri, O. Boyd, L. Cattarino, Others, The global impact of covid-19 and strategies for
mitigation and suppression. On behalf of the imperial college covid-19 response team, Imperial
College of London (2020).

7.

G. BÃ©raud, S. Kazmercziak, P. Beutels, D. Levy-Bruhl, X. Lenne, N. Mielcarek, Y.
Yazdanpanah, P.-Y. BoÃ«lle, N. Hens, B. Dervaux, The French Connection: The First Large
Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases.
PLoS One. 10, e0133203 (2015).

8.

T. W. Russell, J. Hellewell, C. I. Jarvis, K. van Zandvoort, S. Abbott, R. Ratnayake, Cmmid
Covid-Working Group, S. Flasche, R. M. Eggo, W. J. Edmunds, A. J. Kucharski, Estimating the
infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data
from the outbreak on the Diamond Princess cruise ship, February 2020. Euro Surveill. 25
(2020), doi:10.2807/1560-7917.ES.2020.25.12.2000256.

9.

K. Mizumoto, K. Kagaya, G. Chowell, Early epidemiological assessment of the transmission
potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China,
January-February,
2020.
medRxiv
(2020)
(available
at
https://www.medrxiv.org/content/10.1101/2020.02.12.20022434v2.abstract).

20

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

10. L. Peeples, News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine. Proc. Natl.
Acad. Sci. U. S. A. (2020), doi:10.1073/pnas.2005456117.
11. M. Bolles, D. Deming, K. Long, S. Agnihothram, A double-inactivated severe acute respiratory
syndrome coronavirus vaccine provides incomplete protection in mice and induces increased
eosinophilic â€¦. Journal of (2011) (available at https://jvi.asm.org/content/85/23/12201.short).
12. D. Ricke, R. W. Malone, Medical Countermeasures Analysis of 2019-nCoV and Vaccine Risks
for Antibody-Dependent Enhancement (ADE) (2020), , doi:10.2139/ssrn.3546070.
13. J. Wang, K. Tang, K. Feng, W. Lv, High Temperature and High Humidity Reduce the
Transmission of COVID-19. SSRN Electronic Journal, , doi:10.2139/ssrn.3551767.
14. info coronavirus covid 19 - carte et donnees covid 19 en france. Gouvernement.fr, (available
at https://www.gouvernement.fr/info-coronavirus/carte-et-donnees).
15. Field Briefing: Diamond Princess COVID-19 Cases, 20 Feb Update (2020), (available at
https://www.niid.go.jp/niid/en/2019-ncov-e/9417-covid-dp-fe-02.html).
16. æ–°å‹ã‚³ãƒ­ãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã«ã¤ã„ã¦,
(available
https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000164708_00001.html).

at

17. N. M. Linton, T. Kobayashi, Y. Yang, K. Hayashi, A. R. Akhmetzhanov, S.-M. Jung, B. Yuan,
R. Kinoshita, H. Nishiura, Incubation Period and Other Epidemiological Characteristics of 2019
Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available
Case Data. Journal of Clinical Medicine. 9 (2020), p. 538.
18. H. Nishiura, D. Klinkenberg, M. Roberts, J. A. P. Heesterbeek, Early epidemiological
assessment of the virulence of emerging infectious diseases: a case study of an influenza
pandemic. PLoS One. 4, e6852 (2009).
19. Stan Development Team, RStan: the R interface to Stan (2020), (available at http://mcstan.org/).
20. Zhanwei Du, Xiaoke Xu, Ye Wu, Lin Wang, Benjamin J. Cowling, Lauren Ancel Meyers, Serial
Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerging Infectious Disease
journal. 26 (2020), doi:10.3201/eid2606.200357.
21. Q. Bi, Y. Wu, S. Mei, C. Ye, X. Zou, Z. Zhang, X. Liu, L. Wei, S. A. Truelove, T. Zhang, W. Gao,
C. Cheng, X. Tang, X. Wu, Y. Wu, B. Sun, S. Huang, Y. Sun, J. Zhang, T. Ma, J. Lessler, T.
Feng, Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases
and 1,286 of their close contacts. medRxiv, 2020.03.03.20028423 (2020).
22. L. Tindale, M. Coombe, J. E. Stockdale, E. Garlock, W. Y. V. Lau, M. Saraswat, Y.-H. B. Lee,
L. Zhang, D. Chen, J. Wallinga, C. Colijn, Transmission interval estimates suggest presymptomatic spread of COVID-19. Epidemiology (2020), , doi:10.1101/2020.03.03.20029983.
23. S. Funk, socialmixr (Github; https://github.com/sbfnk/socialmixr).
24. O. Diekmann, J. A. Heesterbeek, J. A. Metz, On the definition and the computation of the basic
reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J. Math.
Biol. 28, 365â€“382 (1990).

21

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

25. N. Hens, G. M. Ayele, N. Goeyvaerts, M. Aerts, J. Mossong, J. W. Edmunds, P. Beutels,
Estimating the impact of school closure on social mixing behaviour and the transmission of
close contact infections in eight European countries. BMC Infect. Dis. 9, 187 (2009).
26. DÃ©cret nÂ° 2020-260 du 16 mars 2020 portant rÃ©glementation des dÃ©placements dans le cadre
de la lutte contre la propagation du virus covid-19 | Legifrance, (available at
https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000041728476&categorie
Lien=id).
27. C. I. Jarvis, K. Van Zandvoort, A. Gimma, K. Prem, CMMID COVID-19 working group, P.
Klepac, G. J. Rubin, W. J. Edmunds, Quantifying the impact of physical distance measures on
the
transmission
of
COVID-19
in
the
UK.
Epidemiology
(2020),
,
doi:10.1101/2020.03.31.20049023.
28. J. Wallinga, M. Lipsitch, How generation intervals shape the relationship between growth rates
and reproductive numbers. Proc. Biol. Sci. 274, 599â€“604 (2007).

Funding statement
We acknowledge financial support from the Investissement dâ€™Avenir program, the Laboratoire
dâ€™Excellence Integrative Biology of Emerging Infectious Diseases program (Grant ANR-10-LABX62-IBEID), SantÃ© Publique France, the INCEPTION project (PIA/ANR-16-CONV-0005) and
European Union V.E.O and RECOVER projects. HS would also like to acknowledge support from
the European Research Council (No. 804744).

22

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Supplementary Information
Supplementary tables
Table S1: Probability of hospitalization and ICU by age and sex
Table S2: Probability of death by age and sex
Table S3: Estimated delays from hospitalization to death
Table S4: Parameter estimates from the national model
Table S5: Parameter estimates from the regional model
Table S6: Proportion infected by region by the 11th May.

Supplementary figures
Figure S1: Fit of delay from hospitalization to ICU admission
Figure S2: Relative differences by sex
Figure S3: Fit of delays from hospitalization to death
Figure S4: Fit of delays from hospitalization to death by age
Figure S5: Trajectories predicted by the regional model
Figure S6: Princess Diamond fit
Figure S7: Simulation results
Figure S8: Sensitivity analysis with increased deaths on Princess Diamond
Figure S9: Sensitivity analysis with equal attack rates across age groups
Figure S10: Sensitivity analysis with reduced transmission in <20y
Figure S11: Adjustments to SI-VIC epidemic curves

23

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Table S1: Probability of hospitalization and ICU by age and sex

Age
group

P(Hosp|infected)

P(ICU|Hosp)

Male

Female

Mean

Male

Female

Mean

<20

0.1 (0.060.2)

0.09
(0.05-0.2)

0.1 (0.050.2)

17.5 (13.822.0)

8.5
(5.8-12.1)

13.5
(11.0-16.4)

20-29

0.6 (0.31.0)

0.5 (0.30.8)

0.5 (0.30.9)

12.2 (10.014.8)

6.8
(5.1-8.9)

9.8
(8.3-11.4)

30-39

1.2 (0.62.0)

0.9 (0.51.5)

1.0 (0.61.7)

17.2 (15.219.3)

10.4 (8.812.2)

14.1 (12.815.5)

40-49

1.6 (0.92.7)

1.3 (0.72.2)

1.5 (0.82.4)

24.3 (22.526.3)

14.3 (12.815.9)

19.8 (18.521.0)

50-59

3.2 (1.75.3)

2.5 (1.44.2)

2.8 (1.54.8)

31.7 (30.033.4)

19.0 (17.720.4)

25.9 (24.827.0)

60-69

7.0
(3.7-11.7)

5.3 (2.88.8)

6.1 (3.210.2)

36.4 (34.838.1)

21.6 (20.322.9)

29.7 (28.630.8)

70-79

11.4 (6.119.0)

8.0 (4.313.4)

9.6 (5.116.0)

29.0 (27.730.3)

17.0 (16.018.1)

23.5 (22.624.4)

80+

31.4 (16.752.6)

15.9 (8.526.5)

21.7 (11.636.3)

5.7 (5.26.1)

3.4 (3.0-3.8)

4.6
(4.3-4.9)

Mean

2.9 (1.64.9)

2.3 (1.23.9)

2.6 (1.44.4)

22.4 (21.923.0)

13.3 (12.813.7)

18.2 (18.018.6)

24

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Table S2: Probability of death by age and sex

Age
group

P(Death|Hosp)

Infection fatality proportion

Male

Female

Mean

Male

Female

Mean

<20

1.2 (0.42.8)

<0.001

0.6 (0.21.5)

0.001
(<0.0010.004)

<0.001

0.001
(0.0000.002)

20-29

1.3 (0.62.4)

1.4 (0.62.7)

1.4 (0.82.2)

0.007
(0.0030.02)

0.007
(0.002-0.02)

0.007
(0.003-0.01)

30-39

2.5 (1.83.4)

1.6 (0.91.4)

2.1
(1.6-2.7)

0.03 (0.010.05)

0.01 (0.0060.03)

0.02 (0.010.04)

40-49

3.9 (3.14.7)

3.2 (2.54.1)

3.6 (3.04.2)

0.06 (0.030.1)

0.04 (0.020.07)

0.05 (0.030.09)

50-59

7.5 (668.3)

6.4 (5.67.2)

7.0 (6.47.6)

0.2 (0.10.4)

0.2 (0.080.3)

0.2
(0.1-0.3)

60-69

14.2 (16.215.3)

12.0 (11.013.1)

13.2 (12.513.9)

1.0 (0.51.7)

0.6
(0.3-1.1)

0.8
(0.4-1.4)

70-79

25.3 (24.126.6)

20.7 (19.522.0)

23.2 (22.324.1)

2.9 (1.54.8)

1.7
(0.9-2.8)

2.2
(1.2-3.7)

80+

42.0 (40.743.4)

34.0 (32.735.4)

38.4 (37.439.3)

13.2 (7.022.1)

5.4
(2.9-9.1)

8.3 (4.413.9)

Mean

21.8 (21.322.3)

17.8 (17.318.4)

20.0 (19.620.4)

0.6 (0.31.1)

0.4
(0.2-0.7)

0.5
(0.3-0.9)

25

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Table S3: Estimated delays from hospitalization to death

Age group

Parameters
P(short delay)

Exponential
(for short delay)

Lognormal
(for longer delays)

Mean (days)

Mean (days)

Median (days)

Overall
Mean (days)

<70

0.11

0.67

21.2

12.4

14.0

70-80

0.13

0.67

12.6

8.5

10.3

80+

0.18

0.67

10.5

7.5

8.6

Mean

0.15

0.67

13.2

8.6

10.1

26

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Table S4: Parameter estimates from the national model

Parameter

Estimate with 95% credible interval

Basic reproduction number ğ‘…Q

3.31 [3.18 - 3.43]

Reproduction number after lockdown ğ‘…j8efg8hi

0.52 [0.5 - 0.55]

Overdispersion parameter ğ›¿

0.77 [0.7 - 0.83]

Initial number of cases ğ¼Q

15.83 [9.87 - 26.34]

Mean time spent in ICU 2/ğ‘”86"

17.15 [16.24 - 18.3]

27

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Table S5: Parameter estimates from the regional model
Parameters common to all the regions
Basic reproduction number ğ‘…Q

3.41 [3.32 - 3.49]

Overdispersion parameter ğ›¿

0.91 [0.87 - 0.95]

Reproduction number after lockdown ğ‘…j8efg8hi

0.52 [0.5 - 0.54]

Region specific parameters
Region ğ‘Ÿğ‘’ğ‘”

Mean time spent in ICU
2/ğ‘”57{ 86"

Initial number of cases ğ¼Q 57{

Auvergne-RhÃ´ne Alpes

18.51 [16.71 - 20.5]

1.01 [0.73 - 1.41]

Bourgogne-Franche-ComtÃ©

17.21 [15.34 - 19.41]

0.48 [0.35 - 0.67]

8.7 [7.36 - 10.46]

0.16 [0.11 - 0.22]

Centre-Val de Loire

22.39 [18.29 - 28.57]

0.22 [0.16 - 0.3]

Corse

10.08 [7.67 - 13.65]

0.06 [0.04 - 0.08]

Grand-Est

13.26 [12.51 - 14.1]

2.13 [1.56 - 2.92]

Hauts-de-France

15.63 [14.26 - 17.08]

1.04 [0.76 - 1.44]

Ãle-de-France

20.83 [19.67 - 22.14]

4.79 [3.51 - 6.65]

Nouvelle-Aquitaine

15.94 [13.71 - 18.81]

0.24 [0.17 - 0.34]

Normandie

17.71 [14.88 - 21.58]

0.24 [0.17 - 0.33]

Occitanie

11.85 [10.67 - 13.23]

0.52 [0.38 - 0.72]

Provence-Alpes CÃ´te dâ€™Azur

22.43 [19.44 - 27.22]

0.49 [0.35 - 0.67]

Pays de la Loire

15.88 [13.18 - 19.32]

0.2 [0.14 - 0.28]

Bretagne

28

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Table S6: Proportion infected by region by the 11th May.

Region

Proportion infected (%) (with
95% uncertainty range
stemming from the uncertainty in
the probability of entering ICU
following infection)

Auvergne-RhÃ´ne Alpes

4.4 [2.7 - 8.3]

Bourgogne-Franche-ComtÃ©

5.7 [3.5 - 10.6]

Bretagne

1.8 [1.1 - 3.3]

Centre-Val de Loire

3.1 [1.9 - 5.8]

Corse

5.4 [3.3 - 10.2]

Grand-Est

11.8 [7.4 - 20.5]

Hauts-de-France

6.1 [3.7 - 11.3]

Ãle-de-France

12.3 [7.9 - 21.3]

Nouvelle-Aquitaine

1.4 [0.9 - 2.8]

Normandie

2.6 [1.5 - 4.9]

Occitanie

3.1 [1.9 - 5.9]

Provence-Alpes CÃ´te dâ€™Azur

3.4 [2.1 - 6.4]

Pays de la Loire

1.9 [1.2 - 3.8]

29

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S1: Fit of delay from hospitalization to ICU admission.

Figure S1: Model and observed fit of exponential model use times from hospitalization to ICU
entry across all ages, taking account for the exponentially growing nature of the epidemic.

30

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S2: Relative differences by sex

Figure S2. (A) Relative risk of hospitalization. (B) Relative risk of ICU entry given hospitalization,
(C) Relative risk of death among those hospitalized. (D) Relative risk of death among all those
infected.

31

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S3: Fit of delays from hospitalization to death

Figure S3. (A) Observed and fitted distribution of delays between hospital admission and death.
(B) Model estimates of distribution of rapid decline and slow decline. Models fitted to take into
account that in a growing epidemic, observed deaths will be biased towards ones that die quickly.

32

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S4: Fit of delays from hospitalization to death by age

Figure S4. Fit of mixture models to time from hospitalization to death for different age groups. The
models are mixture models that have both an exponential decay for those that die quickly and a
log-normal component for those that die after longer delays.

33

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S5: Trajectories predicted by the regional model

34

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

35

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

36

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S5: Predictions per French region (A) Auvergne-RhÃ´ne-Alpes ; (B) Bourgogne-FrancheComtÃ© : (C) Bretagne : (D) Centre-Val de Loire ; (E) Corse ; (F) Grand-Est ; (G) Hauts-de-France ;
(H) Ãle-de-France ; (I) Nouvelle-Aquitaine ; (J) Normandie ; (K) Occitanie ; (L) Provence-Alpes CÃ´te
dâ€™Azur; (M) Pays-de la Loire. (1) : Daily ICU admissions. (2) Number of ICU beds (3) Daily number
of infections (logarithmic scale). The green line indicates the time intervention measures were put
in place that limited movement in the country. The dotted lines in panels 3 represent the 95%
uncertainty range stemming from the uncertainty in the probability of entering ICU following
infection.

37

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S6: Princess Diamond fit

Figure S6: The observed (green bars) and fitted (black line) number of deaths from passengers
on board the Princess Diamond who were infected with SARS-CoV-2. Note there is one fatal case
where no age was reported and is therefore excluded from the plot (their death is included in the
model estimation).

38

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S7: Simulation results

Figure S7: Simulation results where epidemics are simulated with known probabilities of infection,
hospitalization, ICU and death. We then use our model framework to re-estimate the parameters.
(A) Estimated (blue) and true (red) probability of hospitalization by age. (B) Estimated (blue) and
true (red) probability of ICU admission by age. (C) Estimated (blue) and true (red) probability of
death by age among those hospitalized.

39

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S8: Sensitivity analysis with increased deaths on Princess Diamond.

Figure S8: Six infected individuals remain in ICU. This sensitivity analysis assumes that half of
these will go on to die. (A) Probability of hospitalization among those infected as a function of age
and sex. (B) Probability of ICU admission among those hospitalized as a function of age and sex.
(C) probability of death among those hospitalized as a function of age and sex. (D) Probability of
death among those infected as a function of age and sex. For each panel, the black line and grey
shaded region represents the overall mean across all ages.

40

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S9: Sensitivity analysis with equal attack rates across age groups

Figure S9: (A) Probability of hospitalization among those infected as a function of age and sex. (B)
Probability of ICU admission among those hospitalized as a function of age and sex. (C) Probability
of death among those hospitalized as a function of age and sex. (D) Probability of death among
those infected as a function of age and sex. For each panel, the black line and grey shaded region
represents the overall mean across all ages.

41

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S10: Sensitivity analysis with reduced transmission in <20y

Figure S10: Sensitivity analysis with reduced infections in those <20y. Sensitivity analysis
where we explore impact of increased levels of asymptomatic infection may result in reduced
transmission among those <20y. (A) Probability of hospitalization among those infected as a
function of age and sex. (B) Probability of ICU admission among those hospitalized as a function
of age and sex. (C) Probability of death among those hospitalized as a function of age and sex. (D)
Probability of death among those infected as a function of age and sex. For each panel, the black
line and grey shaded region represents the overall mean across all ages.

42

medRxiv preprint doi: https://doi.org/10.1101/2020.04.20.20072413; this version posted April 27, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure S11 : Time-series of hospitalizations, ICU admissions and deaths corrected for
reporting delays

Figure S11: Times-series of hospitalizations (A), ICU admissions (B) and deaths (C) from SI-VIC
data, corrected for reporting delays and under-reporting. The SI-VIC system became operational
on the 13th of March. Deaths and ICUs were retrospectively added, however some hospitalizations
that occurred prior to or around this date were likely missed. To account for missing hospitalizations
prior to the 15th of March, we used another reporting system (OSCOURÂ®) that was already
established (blue line in (A)). We also account for delays in reporting to estimate the number of
hospitalizations, ICU admissions and deaths at the right end of the curves (red line in each panel).
See methods section on how these were calculated.

43

